Logo image of NAKA

KINDLY MD INC (NAKA) Stock Fundamental Analysis

NASDAQ:NAKA - US49457M1062 - Common Stock

4.08 USD
+0.8 (+24.39%)
Last: 9/5/2025, 8:00:01 PM
4.19 USD
+0.11 (+2.7%)
After Hours: 9/5/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, NAKA scores 3 out of 10 in our fundamental rating. NAKA was compared to 102 industry peers in the Health Care Providers & Services industry. While NAKA has a great health rating, there are worries on its profitability. NAKA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NAKA has reported negative net income.
NAKA had a negative operating cash flow in the past year.
NAKA Yearly Net Income VS EBIT VS OCF VS FCFNAKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -55.28%, NAKA is not doing good in the industry: 92.16% of the companies in the same industry are doing better.
NAKA's Return On Equity of -60.97% is on the low side compared to the rest of the industry. NAKA is outperformed by 72.55% of its industry peers.
Industry RankSector Rank
ROA -55.28%
ROE -60.97%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAKA Yearly ROA, ROE, ROICNAKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

NAKA has a better Gross Margin (98.73%) than 100.00% of its industry peers.
NAKA's Gross Margin has been stable in the last couple of years.
NAKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 98.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
NAKA Yearly Profit, Operating, Gross MarginsNAKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

NAKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NAKA has more shares outstanding
Compared to 1 year ago, NAKA has an improved debt to assets ratio.
NAKA Yearly Shares OutstandingNAKA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
NAKA Yearly Total Debt VS Total AssetsNAKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

NAKA has an Altman-Z score of 994.64. This indicates that NAKA is financially healthy and has little risk of bankruptcy at the moment.
NAKA's Altman-Z score of 994.64 is amongst the best of the industry. NAKA outperforms 100.00% of its industry peers.
There is no outstanding debt for NAKA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 994.64
ROIC/WACCN/A
WACC8.74%
NAKA Yearly LT Debt VS Equity VS FCFNAKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 12.99 indicates that NAKA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 12.99, NAKA belongs to the top of the industry, outperforming 98.04% of the companies in the same industry.
A Quick Ratio of 12.99 indicates that NAKA has no problem at all paying its short term obligations.
NAKA has a better Quick ratio (12.99) than 98.04% of its industry peers.
Industry RankSector Rank
Current Ratio 12.99
Quick Ratio 12.99
NAKA Yearly Current Assets VS Current LiabilitesNAKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

NAKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.77%.
The Revenue for NAKA has decreased by -27.67% in the past year. This is quite bad
The Revenue has been growing slightly by 2.79% on average over the past years.
EPS 1Y (TTM)-85.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.4%
Revenue 1Y (TTM)-27.67%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-36.08%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAKA Yearly Revenue VS EstimatesNAKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NAKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAKA Price Earnings VS Forward Price EarningsNAKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAKA Per share dataNAKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NAKA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KINDLY MD INC

NASDAQ:NAKA (9/5/2025, 8:00:01 PM)

After market: 4.19 +0.11 (+2.7%)

4.08

+0.8 (+24.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)11-10 2025-11-10
Inst Owners13.16%
Inst Owner ChangeN/A
Ins Owners2.67%
Ins Owner Change71.25%
Market Cap1.53B
AnalystsN/A
Price TargetN/A
Short Float %0.24%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 685.08
P/FCF N/A
P/OCF N/A
P/B 171.14
P/tB 251.71
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.28%
ROE -60.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 98.73%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2456.96%
Cap/Sales 129.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.99
Quick Ratio 12.99
Altman-Z 994.64
F-Score4
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.67%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-36.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-164.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A